Association of Mirabegron With the Risk of Arrhythmia in Adult Patients 66 Years or Older—A Population-Based Cohort Study

This population-based cohort study evaluates the risk of cardiac arrhythmia and other cardiovascular events in patients 66 years or older receiving the β3-adrenoceptor agonist mirabegron.

Na minha lista:
Detalhes bibliográficos
Publicado no:JAMA Intern Med
Main Authors: Tadrous, Mina, Matta, Rano, Greaves, Simon, Herschorn, Sender, Mamdani, Muhammad M., Juurlink, David N., Gomes, Tara
Formato: Artigo
Idioma:Inglês
Publicado em: American Medical Association 2019
Assuntos:
Research Letter
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6632155/
https://ncbi.nlm.nih.gov/pubmed/31305875
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamainternmed.2019.2011
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados